Health
Alma, a Sisram Medical Company, Launches DermaClear 3-in-1 Skin Hydradermabrasion Platform
NUREMBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetic solutions, today announced the launch of DermaClear, a powerful 3-in-1 treatment solution for deep cleansing, nourishment, and hydration of facial skin. DermaClear i...
2020-01-09 17:00
1689
The largest full marathon in China：The 2020 C&D Xiamen Marathon starts
XIAMEN, China, Jan. 9, 2020 /PRNewswire/ -- "Falling in love with a city while running". The 2020 C&D Xiamen Marathon started at7:30 a.m. on January 5, with 35,071 runners having qualified, and 29,805 of them joining the event in the flesh. Runners from 41 countries and regions participated in th...
2020-01-09 16:11
1358
FHA-Food & Beverage spotlights tech innovation and industry transformation in new FoodTech Zone
SINGAPORE, Jan. 9, 2020 /PRNewswire/ -- From novel farming methods to connected
kitchens, thetechnological and investment potential in the food tech space
2020-01-09 12:03
3553
Alma, a Sisram Medical Company, Receives Excellence Award for "Outstanding Business Performance in Japan"
NURNBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, today announced it has been recognized with an Excellence Award for its "outstanding business performance inJapan" in 2019. The annual "Excellence Award" was...
2020-01-09 10:00
1386
Daewoong Infion obtained World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells
SEOUL, South Korea, Jan. 9, 2020 /PRNewswire/ -- Daewoong Infion Co. has
achieved world's first halal certification for animal cells-derived
biopharmaceuticals.
2020-01-09 09:51
3371
Publication of a Toxicological Study: A Milestone for Jennewein Biotechnologie for the GRAS Approval of the HMO-mix
RHEINBREITBACH, Germany, Jan. 9, 2020 /PRNewswire/ -- Jennewein Biotechnology announces another milestone in the worldwide approval of a new product generation, the "HMO-Mix." The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats," w...
2020-01-09 02:26
2556
Symmetry Surgical, Inc. Acquires The O.R. Company
Acquisition strengthens Symmetry's commitment to deliver best-in-class, cost-effective solutions NASHVILLE, Tennessee, Jan. 9, 2020 /PRNewswire/ -- Symmetry Surgical, Inc. ("Symmetry"), is pleased to announce that it has completed its acquisition of The O.R. Company. The O.R. Company develops, m...
2020-01-09 00:37
1353
Waters Corporation Lauded by Frost & Sullivan for Developing the First Truly Smart Mass Spectrometer, the BioAccord LC-MS System
The system was designed to enhance productivity, positioning the user to acquire and process data with a purpose-built LC-MS platform SANTA CLARA, California, Jan. 8, 2020 /PRNewswire/ -- Based on its analysis of the global biopharmaceutical analytical instrumentation market, Frost & Sullivan ...
2020-01-08 21:30
6330
Transcenta Holding Secures $100 Million Series B Plus Financing
HONG KONG and SUZHOU and HANGZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D, and manufacturing of antibody-based therapeutics, announces today that it has sealed a 100 millio...
2020-01-08 21:00
1529
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors
SHANGHAI and PHILADELPHIA, Jan. 8, 2020 /PRNewswire/ -- The Antengene board today announced the appointment of Mr.Mark J. Alles as an independent director of the company, effectiveJanuary 2, 2020. Mr. Alles is the former Chairman and Chief Executive Officer of Celgene Corporation, now a subsidiar...
2020-01-08 20:00
3186
Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201
Data show superior efficacy after four weeks of treatment and more rapid onset of action for CBP-201 compared with data from studies of current standard of care therapy for AD On Day 29, 42.9% and 50.0% of patients receiving CBP-201 300 mg or 150 mg, respectively, achieved "clear/almost clear" s...
2020-01-08 19:00
1053
CStone announces first patient dosed in the Phase III trial of CS1001 in combination with chemotherapy in first-line esophageal squamous cell carcinoma
SUZHOU, China, Jan. 8, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company's anti-PD-L1 antibody CS1001 in combination therapy as first-line treatment in patients wit...
2020-01-08 13:45
3099
Daewoong Pharmaceutical Receives World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells through Indonesian Joint Venture, Daewoong Infion
SEOUL, South Korea, Jan. 8, 2020 /PRNewswire/ -- Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals. Daewoong Pharmaceutical Co., Ltd. (CEO Sengho Jeon) announced that Daewoong Infion, the company's joint venture with Infion, an In...
2020-01-08 11:00
1378
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of HMBD-001 in HER3 Driven Cancers
* HER3 activation is implicated in tumor progression and in acquired resistance to EGFR and HER2 therapies * Study, published in Molecular Cancer Therapeutics, found HMBD-001 to be able to uniquely block HER3 dimerization interface and potently inhibit tumor growth SINGAPORE, Jan. 8, 2020 /PR...
2020-01-08 10:40
859
Innovent and Sirnaomics Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining Sintilimab and RNAi in the US
SUZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, and Sirnaomics Inc. ("Si...
2020-01-08 08:00
9154
Rapid Diagnostics Announces Completion of Asset Purchase and New Corporate Strategies
LONDON, Jan. 8, 2020 /PRNewswire/ -- Rapid Diagnostics ML Limited, UK is pleased to announce the return of its Point of Care (PoC) platform, the MiniLab System. Rapid was formed to purchase the assets and Intellectual Property (IP) of the former Enigma Diagnostics, which was liquidated in 2017. ...
2020-01-08 08:00
2158
Rising Demand for IoT-enabled Pumps to Drive North American PD Pumps Market amid Economic Slowdown
Integration of machine learning, artificial intelligence in pumps to help improve efficiency and reduce maintenance costs, finds Frost & Sullivan SANTA CLARA, California, Jan. 8, 2020 /PRNewswire/ -- Driven by continued investments in the US oil and gas industry, along with increased activity in ...
2020-01-08 06:03
1171
Southstar Drug Gets Ready for the Future with Huawei Wi-Fi 6
MANILLA, Philippines, Jan. 7, 2020 /PRNewswire/ -- Recently, by choosing a wireless Wi-Fi-6 network from Huawei, Southstar Drug is able to operate its business more efficiently and at greater speed, with better access to resources,helping to boost employee productivity. Southstar Drug, a subsidi...
2020-01-08 00:01
1311
Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies
SUZHOU, China and SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced the initiation of an investigational study of GC027, the first product candidate developed usingTruUCAR™ to treat relapsed or refr...
2020-01-07 22:00
1052
Beta Lifescience Announces the Online Availability of Quality Immune Checkpoint Proteins for Scientific Discoveries
FIREFILED, N.J., Jan. 7, 2020 /PRNewswire/ -- Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the...
2020-01-07 21:10
839
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5216
